CanadaBuys #AB-2026-06673

University of Calgary plans to acquire Cobionix CODI Cobot robotic ultrasound platform

The University of Calgary intends to acquire a robotic ultrasound platform for breast cancer care and research. - Government buyer: University of Calgary, Cumming School of Medicine. - OEM: Cobionix Corporation, the named manufacturer of the CODI Cobot platform. - Requested products and services: - One CODI Cobot autonomous medical platform; quantity and part number are not specified. - A three-year software licence for the platform; quantity and part number are not specified. - Purpose: Support standardized breast and axilla ultrasound examinations for breast cancer patients following neo-adjuvant therapy. - Notable technical requirements: Controlled movement, repeatable ultrasound probe positioning, and logging of probe force or pressure. The system must also capture imaging, positional, force, and trajectory data in a synchronized manner for analysis, reproducibility auditing, and research.

Description

The University of Calgary intends to purchase the CODI Cobot autonomous medical platform from Cobionix Corporation, including a three-year software licence agreement. The Cumming School of Medicine will use the platform to improve standardization in breast and axilla ultrasound examinations for breast cancer patients following neo-adjuvant therapy. The platform must support consistent scanning through controlled movement, repeatable probe positioning, and logged probe force or pressure. It must also capture synchronized imaging, positional, force, and trajectory data for analysis, reproducibility auditing, and research use.

View original listing